A new large analysis showed that patients with stage IB non-small cell lung cancer lived longer with adjuvant chemotherapy treatment.
Patients with late-stage, non-small cell lung cancer who had surgery lived longer than those who didn’t, a new data analysis reveals.
Patients with an aggressive type of cancer called malignant pleural mesothelioma improved their quality of life after surgery, a survey reveals.
Olaparib (Lynparza) induced positive patient outcomes in relapsed ovarian cancer patients, especially of the BRCAm mutation.
Immunotherapy drug blinatumomab extended patients life with relapsed acute lymphoblastic leukemia when compared to chemotherapy.
Aspirin can be used to reduce mortality among colon cancer survivors as it may prevent cancer relapse, a new and unique study reports.
Treating pancreatic cancer patients with oral chemotherapy drug capecitabine with gemcitabine prolonged their survival without increasing toxicity.
Elderly glioblastoma patients lived longer after being treated with chemoradiation using temozolomide, new research reveals.
Postmenopausal breast cancer patients had a 34% lower risk of recurrence after receiving hormone therapy letrozole from 5 to 10 years, a new study shows.
The combination of lenvatinib and everolimus received FDA approval for the treatment of advanced renal cell carcinoma following prior anti-angiogenetic therapy.
Adding a second autologous stem-cell transplant to treatment improved outcomes for children with high-risk neuroblastoma, a new research shows.
Adding daratumumab to a standard two-drug regimen reduced the risk of cancer progression in patients with recurrent or refractory multiple myeloma.
Treating metastatic bladder cancer patients with Tecentriq resulted in tumor shrinkage with less toxic effects, researchers say.
Exercise reduced symptoms of neuropathy due to chemotherapy in cancer patients, investigators report.
Treating patients of low-grade serous carcinoma (LGSC) of the ovary or peritoneum with hormonal maintenance therapy improved progression-free survival.
Colorectal cancer patients with depression at time of diagnosis are more likely to have very poor quality of life after treatment, a new research shows.
EU regulators approved ibrutinib for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL).
In two studies, the PD-1 inhibitors pembrolizumab and nivolumab produced long-duration disease control and long-term survival for some melanoma patients.
US regulators approved the PD-L1 inhibitor atezolizumab for the treatment of advanced urothelial cancer, the most common form of bladder cancer.
Scientists found that a specific protocol of chemotherapy, radiation and aggressive surgery led to better long-term survival for pancreatic cancer patients.
Screening patients with a high risk of developing lung cancer can identify early stage disease, improving greatly their survival rates.
Scientists comparing treatment methods for stage II testicular cancer report that radiotherapy is more effective than chemotherapy.
The risk of mental health disorders is increased during the first week of a cancer diagnosis, a new study reports.
Pulmonary metastasectomy was associated to prolonged survival in patients with metastatic soft tissue sarcoma, a new data analysis shows.
Scientists comparing chemoradiotherapy with chemotherapy for the treatment of locally advanced pancreatic cancer report no added survival benefit of chemoradiotherapy.
Treating advanced melanoma patients with radiation combined with immunotherapy induces better results against melanoma, a research shows.
Palliative care showed to improve caregivers’ quality of life and mood creating a powerful positive feedback loop in families facing cancer.
Robotic surgery to remove the prostate reduced risk of blood loss in obese prostate cancer patients, a new study reveals.
Advanced melanoma patients lived longer after being treated with pembrolizumab regardless of whether they received previous treatments, a study shows.
US regulators granted accelerated approval to nivolumab for the treatment of patients with classical Hodgkin lymphoma.